Mississauga, ON (pcJ News Briefs) – MedX Health Corp. (TSX-V: MDX) has closed, effective April 21, 2017, first tranche of previously announced $3 million brokered private placement, issuing 6,948,333 units at $0.12 per unit for gross proceeds of $833,800.
Each unit consists of one common share and one warrant entitling the holder to purchase one additional common share during the period expiring April 21, 2020, at $0.20 per share.
Wildlaw Capital Markets Inc. acts as agent for the offering.
Upon closing, MedX Health has 104,639,494 shares outstanding.
MedX Health Corp. is a medical device company focused on skin cancer with its SIAscopy technology.
photo credit: MedX Health
- PSP Investments acquire minority stake in SitusAMC - April 2, 2020
- Damon Motorcycles secures $3M new funding - April 1, 2020
- PSP Investments and ATRF close $1B acquisition of AltaGas Canada - March 31, 2020